McKesson Completes the Acquisitions of Biologics and Vantage Oncology

SAN FRANCISCO, April 4, 2016 – McKesson Corporation (NYSE:MCK), a leading international healthcare services and information technology company, announced today that it has completed the previously announced acquisitions of Vantage Oncology, LLC, and Biologics, Inc., for a combined purchase price of approximately $1.2 billion.

About McKesson Corporation

McKesson Corporation, currently ranked 11th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit us at www.mckesson.com.

PR Contact
Investors and Financial Media:
Erin Lampert
415-983-8391
Erin.Lampert@McKesson.com

General and Business Media:
Kris Fortner
415-983-8352
Kris.Fortner@McKesson.com